Regret Analysis of Stochastic and Nonstochastic Multi-armed Bandit Problems
Foundations and Trends® in Machine Learning · 2012-12-12 · 5 (1) · 1-122
DOI: 10.1561/2200000024 ↗At a glance
Journal article in Foundations and Trends® in Machine Learning, published online on 2012-12-12. Written by Sébastien Bubeck and 1 co-authors. Cited 1124 times so far (Crossref); 175 references.
Abstract (original language)
Multi-armed bandit problems are the most basic examples of sequential decision problems with an exploration–exploitation trade-off. This is the balance between staying with the option that gave highest payoffs in the past and exploring new options that might give higher payoffs in the future. Although the study of bandit problems dates back to the 1930s, exploration–exploitation trade-offs arise in several modern applications, such as ad placement, website optimization, and packet routing. Mathematically, a multi-armed bandit is defined by the payoffs process associated with each option. In this monograph, we focus on two extreme cases in which the analysis of regret is particularly simple and elegant: i.i.d. payoffs and adversarial payoffs. Besides the basic setting of finitely many actions, we also analyze some of the most important variants and extensions, such as the contextual bandit model.
Cite
APA
Bubeck, S., & Cesa-Bianchi, N. (2012). Regret Analysis of Stochastic and Nonstochastic Multi-armed Bandit Problems. Foundations and Trends® in Machine Learning, 5(1), 1-122. https://doi.org/10.1561/2200000024
Vancouver
Bubeck S, Cesa-Bianchi N. Regret Analysis of Stochastic and Nonstochastic Multi-armed Bandit Problems. Foundations and Trends® in Machine Learning. 2012;5(1):1-122. doi:10.1561/2200000024
BibTeX
@article{Bubeck2012,
author = {Bubeck, Sébastien and Cesa-Bianchi, Nicolò},
title = {Regret Analysis of Stochastic and Nonstochastic Multi-armed Bandit Problems},
journal = {Foundations and Trends® in Machine Learning},
year = {2012},
volume = {5},
number = {1},
pages = {1--122},
doi = {10.1561/2200000024}
}
EUVIMED